Olanzapine-Induced Mania in Bipolar Spectrum Disorder:A Case Report
Abstract
Objective: To report the case of a 46-year old male with major depressive disorder, who represented manic symptoms, when olanzapine was added to his treatment.
Method: A 46-year old female, with a diagnosis of treatment resistant depression was referred to the authors. He had past history of depression for more than 20 years. The symptoms were present nearly every day since 1981, without any distinct period of remission, nor any noticeable fluctuation. His irritability had been disruptive to his family all these years. His doctor had prescribed maprotiline 25 mg/day, and lorazepam, 2mg/day, in addition to fluoxetine for the last 5 months. He is also a father of two children with methylphenidateresistant and sodium valproate-responsive attention-deficit hyperactivity disorder. Considering the antidepressant effects of olanzapine and its positive effects on irritability, the authors added olanzapine, to the patient’s previous medications.
Results: After one week, he showed new problems such as talkativeness and beginning to smoke for the first time in his life, elevated mood, grandiosity about his intelligence and abilities, talkativeness, and shopping sprees. The score on the mania rating scale was 14. Fluoxetine was discontinued and sodium valproate, were prescribed. It took around 2 months to completely control the manic symptoms.
Conclusions: In the patients with depression who show bipolar spectrum disorder features, adding mood stabilizers may be preferred to the drugs as olanzapine which could induce mania.
Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-9.
Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo- controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000; 57: 841-9.
Vieta E. The treatment of mixed states and the risk of switching to depression. Eur Psychiatry 2005; 20: 96-100.
Rachid F, Bertschi G, Bondolfi G, Aubry JM. Possible induction of mania or hypomania by atypical antipsychotics: An updated review of reported cases. J Clin Psychiatry 2004; 65: 1537-45.
Aubry JM, Simon AE, Bertschi G. Possible induction of mania or hypomania by olanzapine or risperidone: A critical review of reported cases. J Clin Psychiatry 2000; 61: 649-55.
Fahy S, Fahy TJ. Induction of manic symptoms by novel antipsychotics. Br J Psychiatry 2000; 176: 597.
Narayan G, Puranic A. Olanzapine-induced mania. Int J Psychiatry Clin Pract 2000; 176: 597.
Borysewicz K, Borysewicz W. [A case of mania following olanzapine administration]. Psychiatr Pol 2000; 34: 299-306.
Lykouras L, Gournellis R, Angelopoulos E. Manic symptoms induced by olanzapine. Eur Neuropsychopharmacol 2001; 11: 97-8.
Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999; 22: 517-534, vii.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-35.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994.
Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Br J Psychiatry 2002; 181: 284- 294.
Smith DJ, Muir WJ, Blackwood DHR. Borderline personality disorder characteristics in young adults with recurrent mood disorders: A comparison of bipolar and unipolar depression. J Affect Disord 2005; 87: 17–23.
Kent L, Craddock N. Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J Affect Disord 2003; 73: 211-21.
Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 2005; 86: 1-10.
Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP. Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review. J Affect Disord 2004 15; 82: 167-74.
Files | ||
Issue | Vol 1 No 3 (2006) | |
Section | Articles | |
Keywords | ||
Attention deficit disorder with hyperactivity Bipolar disorder olanzapine Depression |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |